See more : Bolt Projects Holdings, Inc. (BSLK) Income Statement Analysis – Financial Results
Complete financial analysis of Radient Technologies Inc. (RDDTF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Radient Technologies Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Beijing Huayuanyitong Thermal Technology Co., Ltd. (002893.SZ) Income Statement Analysis – Financial Results
- Recyctec Holding AB ser. B (RECY-B.ST) Income Statement Analysis – Financial Results
- Orkla ASA (ORK.OL) Income Statement Analysis – Financial Results
- Revolution Co., Ltd. (8894.T) Income Statement Analysis – Financial Results
- Dillard’s, Inc. (DDS) Income Statement Analysis – Financial Results
Radient Technologies Inc. (RDDTF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.radientinc.com
About Radient Technologies Inc.
Radient Technologies Inc., together with its subsidiaries, processes, manufactures, sells, and distributes cannabis materials in Canada and internationally. It offers vape cartridges or dabs, cannabis oil, standardized cannabinoid ingredients, cannabis extracts, and cannabis formulations. The company also provides extraction services for the extraction, purification, and isolation of cannabinoids for third parties. Its ingredients are used in food and beverage, nutraceuticals, pharmaceuticals, cosmetics, and personal care industries. Radient Technologies Inc. was incorporated in 2001 and is headquartered in Edmonton, Canada.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 3.62M | 2.49M | 18.40M | 214.06K | 455.83K | 293.45K | 626.46K | 131.41K | 181.09K | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 3.43M | 2.98M | 17.96M | 131.25K | 260.72K | 178.88K | 340.05K | 504.39K | 482.05K | 0.00 | 0.00 |
Gross Profit | 0.00 | 188.38K | -495.61K | 447.95K | 82.81K | 195.11K | 114.57K | 286.40K | -372.99K | -300.96K | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 5.20% | -19.91% | 2.43% | 38.69% | 42.80% | 39.04% | 45.72% | -283.84% | -166.20% | 0.00% | 0.00% |
Research & Development | 0.00 | 346.31K | 1.06M | 3.97M | 2.72M | 1.06M | 592.64K | 0.00 | 599.83K | 550.67K | 0.00 | 0.00 |
General & Administrative | 0.00 | 4.74M | 10.15M | 20.06M | 24.12M | 12.22M | 3.12M | 3.07M | 4.53M | 2.96M | 66.69K | 0.00 |
Selling & Marketing | 0.00 | 271.46K | 185.59K | 1.41M | 1.29M | 656.16K | 230.05K | 194.57K | 313.80K | 337.37K | 0.00 | 0.00 |
SG&A | 0.00 | 4.74M | 10.15M | 20.06M | 24.12M | 12.22M | 3.12M | 3.26M | 4.84M | 3.29M | 66.69K | 0.00 |
Other Expenses | 0.00 | 106.51K | -597.28K | 25.04K | 24.33K | 74.37K | 113.85K | 147.97K | -834.51K | 167.59K | 0.00 | 0.00 |
Operating Expenses | 0.00 | 6.80M | 13.37M | 26.26M | 27.96M | 13.83M | 4.17M | 4.19M | 7.04M | 4.55M | 66.69K | 0.00 |
Cost & Expenses | 0.00 | 10.23M | 16.35M | 44.22M | 28.10M | 14.09M | 4.35M | 4.53M | 7.54M | 5.03M | 66.69K | 0.00 |
Interest Income | 0.00 | 323.44K | 446.26K | 230.43K | 444.63K | 66.25K | 22.82K | 19.06K | 9.99K | 107.00 | 4.37K | 0.00 |
Interest Expense | 0.00 | 1.94M | 2.60M | 834.34K | 445.24K | 196.52K | 185.35K | 144.59K | 366.99K | 1.14M | 79.00 | 0.00 |
Depreciation & Amortization | 167.90K | 1.71M | 2.16M | 2.23M | 1.13M | 539.89K | 455.83K | 442.99K | 1.07M | 398.06K | 79.00 | 0.00 |
EBITDA | 0.00 | -5.21M | -12.49M | -23.51M | -26.55M | -13.31M | -3.68M | -3.62M | -7.20M | -4.57M | -3.40M | 0.00 |
EBITDA Ratio | 0.00% | -143.87% | -501.76% | -127.73% | -12,400.87% | -2,914.15% | -1,260.28% | -577.79% | -5,478.59% | -2,080.08% | 0.00% | 0.00% |
Operating Income | 0.00 | -6.92M | -14.65M | -25.73M | -27.67M | -7.90M | -4.05M | -3.53M | -6.47M | -4.86M | -66.76K | 0.00 |
Operating Income Ratio | 0.00% | -191.20% | -588.37% | -139.83% | -12,927.85% | -1,732.56% | -1,381.43% | -563.07% | -4,922.74% | -2,681.44% | 0.00% | 0.00% |
Total Other Income/Expenses | 0.00 | -6.32M | -28.40M | -11.60M | -1.03M | -913.40K | -262.50K | -415.41K | -7.26M | -469.10K | 4.37K | 0.00 |
Income Before Tax | 0.00 | -12.93M | -42.27M | -37.42M | -27.86M | -14.05M | -4.32M | -4.37M | -14.14M | -5.32M | -62.39K | 0.00 |
Income Before Tax Ratio | 0.00% | -357.01% | -1,697.84% | -203.31% | -13,012.97% | -3,081.94% | -1,470.89% | -697.04% | -10,758.75% | -2,940.48% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 2.04M | 2.00M | 859.37K | 424.53K | 195.76K | 360.52K | 334.25K | -440.20K | 1.32M | 0.00 | 0.00 |
Net Income | 0.00 | -12.93M | -42.27M | -37.42M | -27.86M | -14.05M | -4.32M | -4.37M | -14.14M | -5.32M | -62.39K | 0.00 |
Net Income Ratio | 0.00% | -357.01% | -1,697.84% | -203.31% | -13,012.97% | -3,081.94% | -1,470.89% | -697.04% | -10,758.75% | -2,940.48% | 0.00% | 0.00% |
EPS | 0.00 | -0.03 | -0.13 | -0.14 | -0.11 | -0.07 | -0.05 | -0.09 | -0.45 | -22.07 | -0.10 | 0.00 |
EPS Diluted | 0.00 | -0.03 | -0.13 | -0.14 | -0.11 | -0.07 | -0.05 | -0.09 | -0.45 | -22.07 | -0.10 | 0.00 |
Weighted Avg Shares Out | 530.87M | 452.59M | 325.35M | 272.18M | 251.88M | 188.64M | 85.86M | 49.33M | 31.58M | 241.28K | 600.00K | 810.00K |
Weighted Avg Shares Out (Dil) | 530.87M | 452.59M | 325.35M | 272.18M | 251.88M | 188.64M | 85.86M | 49.33M | 31.58M | 241.28K | 600.00K | 810.00K |
Radient Technologies Announces Strategic Licensing Agreement with HighGrade Supply Ltd.
Radient Technologies Signs Definitive Licensing Agreement with Atomic EH to Launch Its First Cannabis Platform with the Indigenous Community
Radient Technologies Announces Close of Private Placement and Shares for Debt arrangements
Radient Technologies Inc. Releases Third Quarter 2021 Financial Results
Radient Technologies Announces Shares for Debt Arrangements and Grants Stock Options
Radient Technologies Announces Close of Subsequent Tranche of Private Placement and Shares for Debt Arrangements
Radient Technologies Announces Shares for Debt Arrangements
Radient Technologies Announces Licensing Agreement with Tunaaaaroom
Radient Technologies Inc. Announces Second Quarter 2021 Financial Results and Provides a Corporate Update
Radient Technologies Announces Receipt of Cannabis Research Licence for Human Administration Trials and Sensory and Taste Evaluation of Cannabis Products
Source: https://incomestatements.info
Category: Stock Reports